Literature DB >> 34137231

TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.

Yeqi Shen1, Zhongxiu Wang1, Jingyi Tan1, Jiahui Zhong1, Lili Chen1.   

Abstract

To investigate the effects of interleukin (IL)-17-mediated autophagy on the TNF receptor associated factor (TRAF6)/extracellular signal-regulated kinase (ERK)/p38 pathway and osteoclast differentiation. Mouse bone marrow-derived macrophages (BMM) were cultured with a medium containing 30 ng/mL macrophage colony stimulating factor and 50 ng/mL receptor activator of nuclear factor-kappa B ligard (RANKL), and IL-17 (0.01, 0.1, 1.0, 10 ng/mL) was added for intervention (IL-17 group). Tartrate-resistant acid phosphatase (TRAP) staining was used to observe TRAP positive multinucleated cells; phalloidin fluorescent staining was used to detect actin ring circumference; toluidine blue staining was used to analyze bone resorption lacuna formation. To further examine the mechanism of the effect of IL-17-mediated autophagy on the differentiation of osteoclasts, the control group used RANKL medium to culture mouse macrophage RAW264.7 cells, while the IL-17 group was treated with IL-17 (0.01, 0.1, 1.0, /mL). Western blot was used to detect the expression of autophagy-related proteins Beclin-1, microtubule-associated protein 1 light chain 3 (LC3) and osteoclast-related proteins c-fos and nuclear factor of activated T cell 1 (NFATc1) after treatment with different concentrations of IL-17. The expression of LC3, NFATc1, TRAF6/ERK/p38 signaling pathway related proteins were detected in IL-17 and autophagy inhibitor 3-MA group. The number of TRAP positive multinucleated cells, the circumference of the actin ring and the area of bone resorption lacuna in IL-17 group treated with IL-17 (0.01, 0.1, were significantly higher than those in the control group. In IL-17 treated RAW264.7 cells, the expression of c-fos, NFATc1, Beclin-1, LC3, TRAF6, p-ERK, and p-p38 was all significantly up-regulated (all 0.05). After treatment with the autophagy inhibitor 3-MA, the expression levels of LC3, NFATc1, TRAF6, p-ERK, and p-p38 all decreased significantly (all 0.05). IL-17 can promote the expression of autophagy proteins and enhance the differentiation ability of osteoclast precursor cells, and the TRAF6/ERK/p38 signaling pathway may be involved in this process.

Entities:  

Keywords:  Autophagy; Cell differentiation; Interleukin-17; Osteoclast; TRAF6/ERK/p38 pathway

Mesh:

Substances:

Year:  2021        PMID: 34137231      PMCID: PMC8710285          DOI: 10.3724/zdxbyxb-2021-0099

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  35 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 2.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

3.  IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.

Authors:  Satoshi Kitami; Hideki Tanaka; Takayuki Kawato; Natsuko Tanabe; Tomoko Katono-Tani; Fan Zhang; Naoto Suzuki; Yoshiyuki Yonehara; Masao Maeno
Journal:  Biochimie       Date:  2010-01-04       Impact factor: 4.079

Review 4.  Periodontal diseases.

Authors:  Denis F Kinane; Panagiota G Stathopoulou; Panos N Papapanou
Journal:  Nat Rev Dis Primers       Date:  2017-06-22       Impact factor: 52.329

5.  RANKL-based osteoclastogenic assays from murine bone marrow cells.

Authors:  Lianping Xing; Brendan F Boyce
Journal:  Methods Mol Biol       Date:  2014

Review 6.  Advances in the regulation of osteoclasts and osteoclast functions.

Authors:  B F Boyce
Journal:  J Dent Res       Date:  2013-08-01       Impact factor: 6.116

7.  IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes.

Authors:  Arnaud Hot; Saloua Zrioual; Myew-Ling Toh; Vanina Lenief; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

Review 8.  The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.

Authors:  Zvi Bar-Shavit
Journal:  J Cell Biochem       Date:  2007-12-01       Impact factor: 4.429

9.  Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.

Authors:  Sara Sprangers; Ton Schoenmaker; Yixuan Cao; Vincent Everts; Teun J de Vries
Journal:  J Cell Physiol       Date:  2015-11-09       Impact factor: 6.384

10.  Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

Authors:  Lu Song; Jingyi Tan; Zhongxiu Wang; Peihui Ding; Qi Tang; Mengjiao Xia; Yingming Wei; Lili Chen
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

View more
  1 in total

1.  Inflamm-Aging-Related Cytokines of IL-17 and IFN-γ Accelerate Osteoclastogenesis and Periodontal Destruction.

Authors:  Jingyi Tan; Anna Dai; Lai Pan; Lan Zhang; Zhongxiu Wang; Ting Ke; Weilian Sun; Yanmin Wu; Pei-Hui Ding; Lili Chen
Journal:  J Immunol Res       Date:  2021-08-04       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.